Glucocorticoids The draft 2021 List, which was considered by WADAs ExCo during its September 2020 meeting, proposed prohibiting all injectable routes of administration of glucocorticoids in-competition
If you're noticing initial thinning, early intervention with GHK-Cu may help maintain density
Place of Service codes 19, 21, 22, 23, 24, 26, 51, 52, and 61 do not allow the physician to separately bill the injection administration code
Researchers should note that despite GHK-Cus favorable safety profile, the subcutaneous or intramuscular administration of peptides in general is associated with injection site pain, lightheadedness, nausea, and even flu-like symptoms in subjects
The short answer is no, CJC 1295 and Ipamorelin are not approved by the FDA for general medical use